This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Eriko Toyoda: Inventor in Pharmaceutical Research.
Introduction
Eriko Toyoda is an inventor associated with Kawasaki, Japan, and Nippon Kayaku Kabushiki Kaisha. Her patent work concerns a pharmaceutical compound intended to modulate immune responses.
Latest Patents
Toyoda is credited with 1 patent: “[1,2,4]Triazolo[1,5-a]pyrimidin-2-ylurea derivative and use thereof.” The invention describes a novel triazolopyrimidine derivative, its prodrug, or a pharmaceutically acceptable salt. The compound is reported to inhibit antigen presentation and is proposed for potential use in preventing or treating transplant rejection, graft-versus-host reactions, autoimmune and allergic diseases, and inflammatory conditions. The patent also describes possible applications as an anticancer drug or as an inducer of immune tolerance for transplanted organs or bone marrow.
Career Highlights
Toyoda’s listed patent reflects research into compounds with potential applications across immunology, transplantation, and cancer treatment. Her work is associated with Nippon Kayaku Kabushiki Kaisha, a company involved in pharmaceutical research and development.
Collaborations
Kan Saiga and Yoshitaka Satoh are identified as Toyoda’s coworkers. Their names provide context for the professional network associated with her work.
Conclusion
Eriko Toyoda’s patent highlights a pharmaceutical invention focused on inhibiting antigen presentation and exploring potential treatments for immune-related conditions, transplantation, and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile